The American Association for Clinical Chemistry's Annual Meeting was recently held in Atlanta and was attended by 18,000 laboratory scientists from 110 countries across the gamut of clinical laboratory medicine. This meeting included more than 400 educational sessions covering subjects from personalized medicine and infectious diseases to point of care and laboratory-developed tests.
In a recent symposium at AACC in Atlanta entitled “The Convergence of Global Point-of-Care Diagnostic Needs,” some interesting ideas and experiences were presented by a diverse panel of experts. As diagnostic testing is moving closer to the patient in developing countries in order to facilitate treatment decisions during the clinical visit and new settings for POCT at decentralized locations such as retail pharmacies within the developed world are emerging, new opportunities and business models can be identified.
It’s no surprise I’ve chosen Project Management as my profession. Planning has always been part of my daily life, and it is a vital part of any successful product development effort. The importance of effective planning has always been clear to me.
Interested in learning about the evolution of Point-of-Care molecular diagnostics? This article provides a very good overview of an area that is attracting both public and private funding and also points out the substantial growth anticipated for this market. Some of the key market drivers include:
Medication nonadherence has long been a major issue for health and healthcare costs. According to one study, “Patient nonadherence to prescribed medications is associated with poor therapeutic outcomes, progression of disease, and an estimated burden of billions per year in avoidable direct health care costs.”
Recently MOHAI hosted an event called “Seattle 20/20: Innovation and Impact” which included a panel of Seattle leaders in a conversation about our region's future as a global innovation hub. It was moderated by John Cook, Co-founder of GeekWire and included Vikram Jandhyala, UW Vice Provost for Innovation and Executive Director of CoMotion; Michael C. Jensen, MD, Director, Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute; Michael Schutzler, CEO, Washington Technology Industry Association; and Dawn Trudeau, Co-Owner, Seattle Storm.
Stratos got the opportunity to host a tour for about twenty 8th grade students. The tour was part of a program called “Making Connections” held by the University of Washington’s Women’s Center. It is a college-readiness program that aims to increase interest in the Science, Technology, Engineering, and Math (STEM) fields.
It’s not lost on us here at Stratos that we are really lucky to have a team of really talented designers and engineers. But what’s even more impressive is the longevity of that team – the average tenure of a Stratos engineer is close to 10 years and we have a significant number who have been with us for well over 15 years.